Our blog

The latest thoughts and announcements from Tidepool's team.

FDA Pre-Cert Pilot Program: Public Input Workshop and Co-Creation

February 20th, 2018 | Howard Look
This is the next in our series of updates on Tidepool’s participation on the FDA Precertification Pilot Program. Prior popular posts include: A Revolution is Occurring: The FDA is leading it, and you may be missing out 101 Questions to Ask Yourself if you are building Medical Software TL;DR From January 29 through February 1, […]
read more

Let’s Talk About Your Insulin Pump Data

February 15th, 2018 | Christopher Snider
TL;DR With this post, we’ll explore bolus and continuous infusion basal information from people who have donated their diabetes data through the Tidepool Big Data Donation Project. Here’s a quick summary of our findings: The analyzed dataset contains data from 803 donors, totaling more than 479 years of insulin pump use. Children are using less […]
read more

Tidepool, Eli Lilly, and the Big Picture

February 6th, 2018 | Howard Look
TL;DR Tidepool has entered into a partnership with Eli Lilly to provide a) use of the Tidepool Clinical Study Platform and b) access to anonymized datasets made possible via the Tidepool Big Data Donation Project. Our partnership has been driven by the team at the Lilly Cambridge Innovation Center, which is developing new and novel […]
read more